Publication | Closed Access

Combination of bendamustine and entinostat synergistically inhibits proliferation of multiple myeloma cells via induction of apoptosis and DNA damage response

Tumor BiologyOncogenic AgentMedicineInhibits ProliferationCell DeathMultiple Myeloma CellsAnti-cancer AgentDna Damage ResponseTumor SuppressorPharmacologyCell BiologyCancer Research